Neogenomics Stock

Neogenomics P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Neogenomics (NEO) as of Jul 24, 2026 is 281.54. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 209.66 — a change of 34.28% (higher).

P/CF

281.54

YoY

34.28%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Neogenomics is 2026 281.54 . P/CF (Price-to-Cash-Flow Ratio) of Neogenomics was 2025 209.66 . It decreases by 34.28% higher compared to the previous year.
Access this data via the Eulerpool API

Neogenomics Stock analysis

What does Neogenomics do? Neogenomics Inc. is a leading company in the field of personalized medicine, based in Fort Myers, Florida. It offers integrated diagnostics and pharmaceutical services for oncology and gene therapy, with a focus on providing accurate diagnosis for cancer patients. Neogenomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neogenomics stock

P/CF (Price-to-Cash-Flow Ratio) of Neogenomics is 281.54 in 2026.

Access this data via the Eulerpool API

Valuation — Neogenomics

All Key Metrics — Neogenomics